These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18281310)

  • 1. Review of corruption in the health sector: theory, methods and interventions.
    Vian T
    Health Policy Plan; 2008 Mar; 23(2):83-94. PubMed ID: 18281310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good governance and corruption in the health sector: lessons from the Karnataka experience.
    Huss R; Green A; Sudarshan H; Karpagam S; Ramani K; Tomson G; Gerein N
    Health Policy Plan; 2011 Nov; 26(6):471-84. PubMed ID: 21169338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring corruption in the South African health sector.
    Rispel LC; de Jager P; Fonn S
    Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.
    Naher N; Hoque R; Hassan MS; Balabanova D; Adams AM; Ahmed SM
    BMC Public Health; 2020 Jun; 20(1):880. PubMed ID: 32513131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isomorphic pressures, institutional strategies, and knowledge creation in the health care sector.
    Yang CW; Fang SC; Huang WM
    Health Care Manage Rev; 2007; 32(3):263-70. PubMed ID: 17666997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Readers' perspectives. Commercial and governmental health care payers should make the use of information technology to detect and prevent fraud and abuse a top priority.
    Health Data Manag; 2003 Jun; 11(6):104. PubMed ID: 12825448
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 8. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing corruption in humanitarian assistance: perceptions, gaps and challenges.
    Maxwell D; Bailey S; Harvey P; Walker P; Sharbatke-Church C; Savage K
    Disasters; 2012 Jan; 36(1):140-60. PubMed ID: 21623891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agencies team up in war against Internet health fraud.
    Bren L
    FDA Consum; 2001; 35(5):9-10. PubMed ID: 11697104
    [No Abstract]   [Full Text] [Related]  

  • 11. Kickbacks, courtesies or cost-effectiveness?: Application of the Medicare antikickback Law to the marketing and promotional practices of drug and medical device manufacturers.
    Bulleit TN; Krause JH
    Food Drug Law J; 1999; 54(3):279-323. PubMed ID: 11797701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in getting workforce research in nursing used for decision-making in policy and practice: a Canadian perspective.
    O'Brien-Pallas L; Hayes L
    J Clin Nurs; 2008 Dec; 17(24):3338-46. PubMed ID: 19146593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using technology to fight fraud.
    Garcia JL
    Health Manag Technol; 2002 Jan; 23(1):32-4. PubMed ID: 11808476
    [No Abstract]   [Full Text] [Related]  

  • 16. Public-Private Partnerships in the health sector: the Danish experience.
    Vrangbaek K
    Health Econ Policy Law; 2008 Apr; 3(Pt 2):141-63. PubMed ID: 18634625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An appraisal of the performance of the economic and financial crimes commission in Nigeria.
    Sowunmi FA; Adesola MA; Salako MA
    Int J Offender Ther Comp Criminol; 2010 Dec; 54(6):1047-69. PubMed ID: 19679650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 19. Health campaigning group calls for action on corruption in India.
    Bagcchi S
    BMJ; 2014 Jul; 349():g4648. PubMed ID: 25028346
    [No Abstract]   [Full Text] [Related]  

  • 20. Shift seen in anti-fraud compliance efforts.
    Saunders B
    Mod Healthc; 1999 Nov; 29(48):26. PubMed ID: 10662200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.